Clene Inc (CLNN) Stock Price, Quote, News & History

CLNNNASDAQ
$5.25
-0.0814-1.53%
Last update: Jun 9, 9:28 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-18.06M
Investing Cash Flow (TTM)
-39.00K
Financing Cash Flow (TTM)
14.08M
Free Cash Flow (TTM)
-18.10M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-4.02M

Analyst Trends and Forecast

1
Dec 25
1
Jan
2
Mar
2
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$84.41M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
421.37
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-60.80%
Earnings Yield % (FWD)
-36.58%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$1.47

Company Debt

Total Debt
$18.20M
LT Debt
$16.34M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$474.00K
Total Cash
$5.94M
Debt to Equity
-
Issuance of Debt (TTM)
$1.03M
Repayment of Debt (TTM)
-$474.00K

Key Statistics

Open
$5.34
Close
-
Volume / Avg.
78.58K / 479.75K
Day Range
$5.25 - $5.72
52 Wk Range
3.25 - 13.50
Market Cap
$67.07M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
37
Short Interest
13.85%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseas...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Clene (CLNN) stock?

A

You can purchase shares of Clene (NASDAQ:CLNN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Clene (CLNN) competitors?

A

There are no as such competitors for Clene.

Q

What is the forecast, or price target, for Clene (CLNN) stock?

A

Clene has a consensus price target of $24.30.

Q

What is the current price for Clene (CLNN)?

A

The stock price for Clene (NASDAQ: CLNN) is $5.2486 last updated June 9, 2026 at 9:28 AM EDT.

Q

Does Clene (CLNN) pay a dividend?

A

There are no upcoming dividends for Clene.

Q

When is Clene (NASDAQ:CLNN) reporting earnings?

A

Clene does not have any upcoming earnings scheduled.

Q

Is Clene (CLNN) going to split?

A

There is no upcoming split for Clene.

Q

What sector and industry does Clene (CLNN) operate in?

A

Clene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.